Journal of Clinical Endocrinology & Metabolism, Vol 47, 572-577, Copyright © 1978 by Endocrine Society

ARTICLES

Pattern of plasma dehydroepiandrosterone sulfate levels in humans from birth to adulthood: evidence for testicular production

E de Peretti and MG Forest

Plasma levels of dehydroepiandrosterone sulfate (DHAS) were measured in 513 normal full term newborns, infants, children, adolescents, and adults and the results were expressed in micrograms per dl. In infancy and childhood, DHAS levels were similar in both sexes. In 74 neonates, mixed cord blood mean values /+- SD were 134.6 +/- 64. During the first day of life, plasma DHAS levels were 140 +/- 125 in 33 neonates. During the first month of life, DHAS decreased drastically, then more progressively until the 6th month of life. Between 1-6 months of age, mean levels were 5.9 +/- 4.7 in 40 children. DHAS was very low between 1-6 yr of life (2.3 +/- 1.6) and rose abruptly at the 7th year of life. Thereafter, DHAS continued to increase correlatively with age and pubertal stages in both sexes, a further increase after age 16 or pubertal stage P5 was noted only in male subjects. In adults, DHAS was significantly higher in male (224 +/- 93) than in female (138.3 +/- 51) subjects. DHAS levels were compared to those of dehydroepiandrosterone; at two periods of life, early infancy and adulthood, their patterns differed. After long term hCG stimulation, DHAS increased significantly in 45 normal prepubertal boys and in 2 boys with adrenal insufficiency. These data would suggest a direct testicular production of DHAS.

This article has been cited by other articles:

				R. L. Rosenfield Identifying Children at Risk for Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 787 - 796. [Abstract] [Full Text] [PDF]

				F. M. Ducharme, G. Chabot, C. Polychronakos, F. Glorieux, and B. Mazer Safety Profile of Frequent Short Courses of Oral Glucocorticoids in Acute Pediatric Asthma: Impact on Bone Metabolism, Bone Density, and Adrenal Function Pediatrics, February 1, 2003; 111(2): 376 - 383. [Abstract] [Full Text] [PDF]

				F. G. Riepe, P. Mahler, W. G. Sippell, and C.-J. Partsch Longitudinal Study of Plasma Pregnenolone and 17-Hydroxypregnenolone in Full-Term and Preterm Neonates at Birth and during the Early Neonatal Period J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4301 - 4306. [Abstract] [Full Text] [PDF]

				M. R. Palmert, D. L. Hayden, M. J. Mansfield, J. F. Crigler Jr., W. F. Crowley Jr., D. W. Chandler, and P. A. Boepple The Longitudinal Study of Adrenal Maturation during Gonadal Suppression: Evidence That Adrenarche Is a Gradual Process J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4536 - 4542. [Abstract] [Full Text] [PDF]

				L. Ibáñez, J. DiMartino-Nardi, N. Potau, and P. Saenger Premature Adrenarche--Normal Variant or Forerunner of Adult Disease? Endocr. Rev., December 1, 2000; 21(6): 671 - 696. [Abstract] [Full Text]

				T. R. Fears, R. G. Ziegler, J. L. Donaldson, R. T. Falk, R. N. Hoover, F. Z. Stanczyk, J. B. Vaught, and M. H. Gail Reproducibility Studies and Interlaboratory Concordance for Androgen Assays in Female Plasma Cancer Epidemiol. Biomarkers Prev., April 1, 2000; 9(4): 403 - 412. [Abstract] [Full Text]

				C. Berr, S. Lafont, B. Debuire, J.-F. Dartigues, and E.-E. Baulieu Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: A French community-based study PNAS, November 12, 1996; 93(23): 13410 - 13415. [Abstract] [Full Text] [PDF]

				P. B. Kaplowitz, J. L. Cockrell, and R. B. Young Premature Adrenarche: Clinical and Diagnostic Features Clinical Pediatrics, January 1, 1986; 25(1): 28 - 34. [Abstract] [PDF]